News
03-31-2009, 02:00 AM
Combining a compound known as a gallium corrole with a protein carrier results in a targeted cancer therapy that is able to detect and eliminate tumors in mice with seemingly fewer side effects than other breast-cancer treatments, says a team of researchers from the California Institute of Technology (Caltech), the Israel Institute of Technology (Technion) and the Cedars-Sinai Medical Center.
More... (http://www.news-medical.net/?id=47653)
More... (http://www.news-medical.net/?id=47653)